BioMed X and Merck extend research collaboration
The two entered a partnership in 2013 and the resulting research has led to 25 scientific publications
Breaking News
Thermo Fisher collaborates with the University of Sheffield
The pair will work to advance complex oligonucleotide characterisation and analytical workflows
Boehringer Ingelheim becomes founding member of QUTAC
The Quantum Technology and Application Consortium believes that quantum computing holds enormous potential for the ...
Orgenesis to trial Tissue Genesis Icellator tech for cell recovery
The trial is supported by the National Stem Cell Foundation and an OREF clinical research grant in cellular therapy in ...
Humans, hybrid models and the power of collaboration: part II
Dr Kevin Robinson recently spoke to Diane Diehl, Senior Director of Scientific Operations at Waters Corp., to discover ...
Aptamer and PinotBio collaborate on drug conjugates
Aptamer will provide the developed Optimers to Pinotbio for use with its payload and linker technologies, while ...
Sanofi and GSK COVID-19 vaccine shows promising Phase II results
The companies plan to initiate the Phase III, randomised, double-blind study with the 10 µg dose, in combination with ...
From dark art to an age of enlightenment
Much is happening in the realms of Almac’s GMP peptides business in terms of growth, development and strategic ...
Researchers develop RNA-based antiviral technique
In a study published in Angewandte Chemie, researchers have reportedly shown how this approach could be effective ...
Hubrecht Institute licenses reagent antibodies for cancer research
The Clevers group dedicates its activity to the study of the molecular mechanisms of tissue development and cancer of ...
Humans, hybrid models and the power of collaboration: part I
Dr Kevin Robinson recently spoke to Diane Diehl, Senior Director of Scientific Operations at Waters Corp., to discover ...
The application of picodroplet technology for biopharmaceutical discovery and scientific research
Picodroplet technologies continue to push the boundaries of biologic discovery by accelerating research, expanding the ...
Bispecific antibodies: an exciting new class of emerging therapeutics
Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...
Swedish researchers develop antibacterial wound dressing
The World Health Organization describes antibiotic-resistant bacteria as one of the greatest threats to global health
Long-acting injectable medicine as potential route to COVID-19 therapy
CELT was established as part of a £30.5 million ($40m) international research consortium, primarily funded by Unitaid
In Brief
Most Popular in Research
Featured Companies
Reports
